Since hepatic insulin resistance and T2DM have been considered sequelae of NAFLD [42], ANGPTL3 could possibly affect glucose levels by inducing NAFLD through lipolysis and increased FFA flux to the liver [42]. Here, ANGPTL3 is linked to metabolic dysfunction-associated steatotic liver disease.